Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Childs Nerv Syst ; 34(11): 2149-2153, 2018 11.
Article in English | MEDLINE | ID: mdl-30120533

ABSTRACT

BACKGROUND: Osteogenic sarcoma of the skull is uncommon and long-term outcome is not well defined. We review the literature and present a pediatric case of calvarial osteogenic sarcoma with good long-term oncological and cosmetic outcome and excellent quality of life. This case presented major surgical challenges, which are detailed. CASE DESCRIPTION: A 6-year-old boy presented with a painless 5 cm × 5 cm lump over the vertex region. He was neurologically normal. Imaging showed an extensive bony lesion with intradural extension. After incisional biopsy showed probable low grade osteosarcoma, a complete en bloc resection with margins was attempted via a concentric craniotomy around the lesion after embolization to reduce blood loss. Invasion of the brain by the tumor precluded the complete en bloc resection, but gross total resection was achieved. The final pathology was consistent with a low-grade osteosarcoma and adjuvant chemotherapy was provided. Follow-up for 8 years has shown no recurrence with good cosmetic and functional outcome.


Subject(s)
Osteosarcoma/pathology , Skull Neoplasms/pathology , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Child , Combined Modality Therapy/methods , Craniotomy/methods , Humans , Male , Osteosarcoma/drug therapy , Osteosarcoma/surgery , Skull Neoplasms/drug therapy , Skull Neoplasms/surgery , Treatment Outcome
2.
Am J Med Genet A ; 164A(10): 2490-5, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24995648

ABSTRACT

Serpentine fibula polycystic kidney syndrome (SFPKS; OMIM600330) is a rare skeletal dysplasia with a characteristic phenotype that includes polycystic kidneys, S-shaped fibulas, and abnormal craniofacial features. SFPKS shares features with Alagille (AGS; OMIM) and Hajdu-Cheney (HCS; OMIM10250) syndromes. All three syndromes result from mutations in the gene that encodes NOTCH2, one of the receptors involved in Notch signaling. Notch signaling is a major developmental signaling pathway, as well as a key regulator of numerous cellular processes. In this report, we present the prenatal ultrasound and postnatal findings in a 23-week fetus with severe manifestations of SPKS and heterozygosity for a de novo mutation in exon 34 of NOTCH2. These findings expand the phenotypic spectrum of NOTCH2 mutations and demonstrate the findings in the prenatal period.


Subject(s)
Hajdu-Cheney Syndrome/genetics , Hajdu-Cheney Syndrome/pathology , Receptor, Notch2/genetics , Exons/genetics , Fetus/pathology , Heterozygote , Humans , Mutation/genetics , Prenatal Diagnosis/methods , Receptors, Notch/genetics , Signal Transduction/genetics
3.
J Mol Diagn ; 16(3): 361-70, 2014 May.
Article in English | MEDLINE | ID: mdl-24517889

ABSTRACT

Childhood sarcomas can be extremely difficult to accurately diagnose on the basis of morphological characteristics alone. Ancillary methods, such as RT-PCR or fluorescence in situ hybridization, to detect pathognomonic gene fusions can help to distinguish these tumors. Two major deficiencies of these assays are their inability to identify gene fusions at nucleotide resolution or to detect multiple gene fusions simultaneously. We developed a next-generation sequencing-based assay designated ChildSeq-RNA that uses the Ion Torrent platform to screen for EWSR1-FLI1 and EWSR1-ERG, PAX3-FOXO1 and PAX7-FOXO1, EWSR1-WT1, and ETV6-NTRK3 fusions of Ewing sarcoma (ES), alveolar rhabdomyosarcoma, desmoplastic small round cell tumor, and congenital fibrosarcoma, respectively. To rapidly analyze resulting data, we codeveloped a bioinformatics tool, termed ChildDecode, that operates on a scalable, cloud-computing platform. Total RNA from four ES cell lines plus 33 clinical samples representing ES, alveolar rhabdomyosarcoma, desmoplastic small round cell tumor, and congenital fibrosarcoma tumors was subjected to ChildSeq-RNA. This accurately identified corresponding gene fusions in each tumor type, with no examples of false positive fusion detection in this proof-of-concept study. Comparison with previous RT-PCR findings demonstrated high sensitivity (96.4%; 95% CI, 82.3%-99.4%) and specificity (100%; 95% CI, 56.6%-100%) of ChildSeq-RNA to detect gene fusions. Herein, we propose ChildSeq-RNA as a novel tool to detect gene fusions in childhood sarcomas at single-nucleotide resolution.


Subject(s)
High-Throughput Nucleotide Sequencing/methods , Oncogene Proteins, Fusion/genetics , Sarcoma/genetics , Sequence Analysis, RNA/methods , Cell Line, Tumor , Child , Humans , Oncogene Fusion/genetics , Paired Box Transcription Factors/genetics , RNA/genetics , Sensitivity and Specificity
5.
Arch Pathol Lab Med ; 133(2): 289-94, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19195972

ABSTRACT

CONTEXT: Eosinophilic cystitis (EC) is an inflammatory condition of the bladder that has been linked to food allergens, infectious agents, drugs, and other genitourinary conditions. Like interstitial cystitis, EC has a strong female predominance. It is characterized by an intense eosinophilic infiltrate in the acute phase and fibrosis in the chronic phase. OBJECTIVES: To document and focus on specific features of EC in males and highlight the relationship between clinical and histopathologic findings. DESIGN: The bladder biopsies of male patients were reviewed. Eight cases of EC were selected. RESULTS: Several known associations were noted as well as unreported features and associations such as Charcot-Leyden crystals, celiac disease, lupus anticoagulant, and additional viral and bacterial agents. CONCLUSIONS: Eosinophilic cystitis represents a response to a variety of agents and may often be overlooked. The temporally biphasic morphologic features are the hallmark of this condition. Because clinical and imaging studies are not specific, a high index of clinical suspicion is often crucial to the correct diagnosis and proper management of EC.


Subject(s)
Cystitis/diagnosis , Cystitis/pathology , Eosinophils/pathology , Adult , Aged , Biopsy , Cystectomy , Cystitis/therapy , Glycoproteins/metabolism , Histamine Antagonists/therapeutic use , Humans , Infant , Lysophospholipase/metabolism , Male , Middle Aged , Urinary Bladder/metabolism , Urinary Bladder/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...